Kall, Meaghan

Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern

Andrews, N., Stowe, J., Kirsebom, F., Toffa, S., Rickeard, T., Gallagher, E., Gower, C., Kall, M., Groves, N., O’Connell, A.-M., et al. (2021) · New England Journal of Medicine

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy

Cited by 2,420

COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study

Hall, V. J., Foulkes, S., Saei, A., Andrews, N., Oguti, B., Charlett, A., Wellington, E., Stowe, J., Gillson, N., Atti, A., et al. (2021) · The Lancet

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy

Cited by 767

Epidemiology of confirmed COVID-19 deaths in adults, England, March–December 2020

Brown, A. E., Heinsbroek, E., Kall, M. M., Allen, H., Beebeejaun, K., Blomquist, P., Campos-Matos, I., Campbell, C. N. J., Mohammed, H., Sinka, K., et al. (2021) · Emerging Infectious Diseases

COVID-19 Clinical Research StudiesCOVID-19 epidemiological studies

Cited by 29